1/11/2012

Higher generic drug utilization rates and higher Medicaid prescription drug rebates were among the factors that kept the growth in drug spending in the U.S. to just 1.2% in 2010, according to CMS data.

Full Story:
PharmaTimes (U.K.)

Related Summaries